BOLETÍN FCV OCTUBRE 2020

In various press releases, it has been highlighted the work that the Scientific Director of Fundación Ciencia & Vida, Pablo Valenzuela, developed along with one of the winners of the Nobel Prize in Medicine 2020, Michael Houghton, in the beginnings of their research against the blood transmition of Hepatitis.

For more information:

Members of the Molecular Virology Lab of Fundación Ciencia & Vida, led by Nicole Tischler, participated in a collaborative work published in the prestigious Journal Cell, titled “The Hantavirus Surface Glycoprotein Lattice and Its Fusion Control Mechanism”.

For more information:

Researchers from the Bioinformatics and Genome Biology Lab of Fundación Ciencia & Vida, led by David Holmes, participated in an article published along with the Curtin University of Australia, titled “Genome-based classification of Acidihalobacter prosperus F5 (=DSM 105917=JCM 32255) as Acidihalobacter yilgarnensis sp. nov. Open Access”.

For more information:

The associate researcher from Fundación Ciencia & Vida, Verónica Burzio, participated in the “Targeting Mitochondria Congress” carried out in Berlin, giving the talk titled “Targeting long noncoding mitochondrial RNA for cancer therapy”

For more information:

Reportage done by “Las Últimas Noticias” highlights the research done by the Lab group of Neuroimmunology of Fundación Ciencia & Vida, led by Rodrigo Pacheco, which shed lights in an opportunity to develop a treatment against Parkinson’s disease by intervening the immune system.

For more information, please visit:
– Nota LUN – 31 Octubre

Researchers from the Bioinformatics and Genome Biology Lab of Fundación Ciencia & Vida, led by David Holmes, participated in a published article titled “AciDB 1.0: a database of acidophilic organisms, their genomic information and associated metadata”.

For more information:

Tomás Pérez-Acle, director of the Computational Biology Lab of Fundación Ciencia & Vida, participated in the “America Interciencia” meeting, organized by the Brasilian Society for Science Progress (SBPC), talking about how the COVID-19 pandemic has been lived in Chile.

For more information, please visit:

A reportage done by “Diario Financiero” spotlights the growing of “Phage Lab”, entrepreneurship associated to Fundación Ciencia & Vida, that now is expanding on an international level.

For more information:

The work led, by Enrique Brandan, researcher from Fundación Ciencia & Vida, is key to develop a new treatment to combat the progression of this pathology, genetic in its origin, that causes deterioration of the muscles and weakness and that, to this date, has no cure.

For more information:

Executive Director of Fundación Ciencia & Vida, Mario Rosemblatt, participated in a press release talking about the premiere of the TV show “Exploradores: Del Átomo al Cosmos”, done by Fundación Ciencia & Vida.

For more information:

Tomás Pérez-Acle, Head of the Compuational Biology Lab of Fundación Ciencia & Vida, participated in various press interviews to analyze the most recent news regarding the emergency caused by coronavirus infections.

For more information, visit:

The head of the Biology of Neurodegeneration Lab, María Soledad Matus, participated in a press release to analyze the effects of quarantines over the mental health of the population.

For more information, please visit:
– Mercurio de Valparaíso – 09 octubre

Cristián Hernández, Business Director of Fundación Ciencia & Vida, analyzes various aspects of scientific news in the context of the coronavirus pandemic, especially those regarding to advances in biotechnology.

For more information:

Researcher from the Molecular Virology Lab of Fundación Ciencia & Vida, Nicolás Muena, participated in various press releases to talk about scientific news related to the coronavirus pandemic.

For more information, visit:
– Canal 13 – 28 octubre
– Radio Sonar – 27 octubre
– El Mercurio – 22 octubre
– La Tercera – 22 octubre
– Radio Duna – 15 octubre
– Las Últimas Noticias – 08 octubre